Download Files:
Products Details
Product Description
– Rongliflozin (DJT1116PG) is a selective and orally active inhibitor of sodium-glucose co-transporter-2 (SGLT-2). Rongliflozin can be used for the research of type 2 diabetes mellitus (T2DM)[1].
Web ID
– HY-153113
Shipping
– Room temperature
Molecular Formula
– C23H27ClO7.C5H7NO3.5/4H2O
References
– [1]Zhang H, et al. Pharmacokinetics and pharmacodynamics of rongliflozin, a novel selective inhibitor of sodium-glucose co-transporter-2, in people with type 2 diabetes mellitus. Diabetes Obes Metab. 2020 Feb;22(2):191-202.
CAS Number
– 2648020-91-9
Molecular Weight
– 602.55
SMILES
– OC([C@H]1NC(CC1)=O)=O.O[C@H]2[C@]3(C4=CC(CC5=CC=C(C=C5)OCC)=C(C=C4)Cl)O[C@@](CO3)([C@H]([C@@H]2O)O)[C@H](O)C.O.[1.25]
Clinical Information
– Phase 1
Research Area
– Endocrinology
Solubility
– 10 mM in DMSO
Target
– SGLT
Pathway
– Membrane Transporter/Ion Channel
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
